Page last updated: 2024-08-25

rosiglitazone and Uremia

rosiglitazone has been researched along with Uremia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chernichovski, T; Filip, I; Ingbir, M; Levin-Iaina, N; Levo, Y; Reshef, R; Rozovski, U; Schwartz, D; Schwartz, IF; Shtabsky, A1
Bhandari, S; Semple, DJ; Seymour, AM1
Chow, KM; Lam, CW; Leung, CB; Li, PK; Szeto, CC; Wong, TY1
Scherbaum, WA1

Trials

1 trial(s) available for rosiglitazone and Uremia

ArticleYear
Rosiglitazone reduces insulin requirement and C-reactive protein levels in type 2 diabetic patients receiving peritoneal dialysis.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 46, Issue:4

    Topics: Aged; C-Reactive Protein; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Injections, Subcutaneous; Insulin; Insulin Resistance; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Rosiglitazone; Thiazolidinediones; Uremia; Weight Gain

2005

Other Studies

3 other study(ies) available for rosiglitazone and Uremia

ArticleYear
Rosiglitazone improves aortic arginine transport, through inhibition of PKCalpha, in uremic rats.
    American journal of physiology. Renal physiology, 2008, Volume: 295, Issue:2

    Topics: Animals; Aorta; Arginine; Biological Transport; Cationic Amino Acid Transporter 1; Disease Models, Animal; Hypoglycemic Agents; Kidney Failure, Chronic; Male; Nitric Oxide; Protein Kinase C-alpha; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Uremia

2008
Uremic cardiomyopathy is characterized by loss of the cardioprotective effects of insulin.
    American journal of physiology. Renal physiology, 2012, Nov-01, Volume: 303, Issue:9

    Topics: Animals; Cardiomyopathies; Cardiotonic Agents; Disease Models, Animal; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rosiglitazone; Thiazolidinediones; Uremia

2012
Do patients with type 2 diabetes on peritoneal dialysis need less insulin if they are given rosiglitazone?
    Nature clinical practice. Nephrology, 2006, Volume: 2, Issue:6

    Topics: Aged; C-Reactive Protein; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Injections, Subcutaneous; Insulin; Insulin Resistance; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Rosiglitazone; Thiazolidinediones; Uremia; Weight Gain

2006